diabetes



Nano One Materials Corp.
Latest Comments
image_pdfimage_print

Diagnos’ André Larente on Entering the DACH and Central European Healthcare Market

In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente President of Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) […]


Does Sernova have a cure for Type 1 Diabetes?

There are many impressive companies around the world trying to solve the world’s problems and make this a better place […]


Diagnos’ Andre Larente on the benefits of using AI for the early detection of critical health issues

“Our (AI) technology works, its in production (CARA). We are fully funded….the markets we are going after are extremely big…” […]


Non-invasive diabetes test provides “Miraculins” results through technology

June 12, 2015 — Tracy Weslosky, Editor-in-Chief and Publisher of InvestorIntel speaks to Christopher Moreau, President, CEO & Director for […]


The big business of age-management through skin pre-testing

It was my perception in meeting Miraculins Inc. (TSXV: MOM), CEO Chris Moreau last night that he is dedicated to […]


Miraculins on the $90mm value non-invasive diabetes test deal and pioneering diagnostic testing

January 27, 2015 — Tracy Weslosky, Editor-in-Chief and Publisher of InvestorIntel speaks to Christopher Moreau, President, CEO & Director for […]